Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study

NCT05947448 · clinicaltrials.gov ↗

UNKNOWN

Status

1215

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Azilsartan Medoxomil Potassium Tablet
DRUG: Nifedipine Sustained -release Tablets
DRUG: Levoamlodipine Maleate Table

Sponsor

Hasten Biopharmaceutical Co., Ltd.